CC was neither bad nor exciting, but I believed overall okay
Ted impressed me. He sounded sincere. He thanked the longterm shareholders twice in the CC. Everybody needs to understand that there's too much at stake to reveal TLD prematurely. They will do it we they are ready. End of story. I liked the clear plan of RS, and uplisting now that legacy issues are behind us. No more toxic financing. Tomorrow may be reactionary to the CC and be negative, but in next weeks to months I predict upward trend for pps. I am staying in, too much upside here to leave now IMO.
Although it's certainly possible that I have been duped by management's words, as a doctor, I really do believe in this RPE stem-cell stuff. I believe it's a game changer, and there's a real potential to help many, many visually-impaired individuals in such a meaningful way. To me, it is worth the riskiness of the investment. Anyway, I prefer being a long-term investor to help the blind see, rather than owning stock, say for example, in a tobacco company with good earnings and a solid balance sheet!